Sign inJoin waitlistJoin the waitlist

Timothy Henry

Medical Director, The Carl & Edyth Lindner Center for Research & Education · Christ Hospital

Credentials: · · · · · · · ·

History

The Carl & Edyth Lindner Center for Research & Education · Christ Hospital
Present
The Carl and Edyth Lindner Center for Research and Education · Baylor College of Medicine
Present

Interventional Cardiology
1988–1989
Cardiovascular Disease
1985–1988
Internal Medicine
1982–1985
University of California, San Francisco School of Medicine
1978–1982

Research

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Circulation · 2017 · 1,500 citations
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
Journal of the American College of Cardiology · 2009 · 1,030 citations
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
Circulation · 2003 · First of 16 authors · Corresponding · 825 citations

Jay Traverse
90 papers
Roxana Mehran
64 papers
SS
Scott Sharkey
50 papers
Giora Weisz
45 papers
George Dangas
42 papers
Carl Pepine
41 papers
Santiago Garcia
41 papers
Usman Baber
39 papers
Thomas Stuckey
38 papers
GS
Gregg Stone
36 papers
Ajay Kirtane
35 papers
LM
Lem Moye
33 papers

Grants

MN Regional Cardiovascular Cell Therapy Clinical Res. Network: From AMI to PAD
National Heart, Lung, and Blood Institute · UM1
Contact PI · $5.1M · Allina Health System
2007–2020
MN Cardiovascular Cell Therapy Clinical Research Network: From AMI to CHF
National Heart, Lung, and Blood Institute · U01
Contact PI · $1.9M · University of Minnesota
2007–2012
31p Nmr Myocardial Bioenergetics in Failing Myocardium
National Heart, Lung, and Blood Institute · F32
Contact PI · $50K · University of Minnesota
1990

Clinical trials

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Principal investigator · Recruiting
Shockwave Medical, Inc.
2022–2032
Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)
Principal investigator · Completed · Phase 2
Cytori Therapeutics
2014–2016
Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia
Principal investigator · Completed · Phase 2
Cytori Therapeutics
2012–2016
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Principal investigator · Completed · Phase 2
Vericel Corporation
2009–2013